Metamol Theranostics logo
VerifiedMedical and Diagnostic Laboratories

Metamol Theranostics

A NEW Test to Determine Breast Cancer Risk.A Breakthrough! Women with lumps in their breasts have to make a difficult decision whether or not to undergo treatment. For these women, a NEW TEST can help in the assessment of their cancer risk and hugely facilitate their decision-making process. We have studied a protein (called hOPN-c), which serves this purpose. The presence of hOPN-c in a lump indicates an elevated risk for breast cancer down the road, and the more of it is detected the more substantive is the risk. A pathologist can simply apply this test to a biopsy

7-day free trial · no credit card

HeadquartersCincinnati, United StatesEmployees2(1 to 10)Annual revenue<$1MWebsitemetamol.comLinkedIn profileLinkedIn

Verified contacts

1

available on Kipplo

LinkedIn employees

2

1 to 10 range

Open roles

no listings

Distinct roles

0

indexed titles

Tech stack

1

tools in use

Monthly traffic

organic / mo

Sign up free to see all 1 verified contacts at Metamol Theranostics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

1 contacts with verified email or phone · masked until revealed.

Sign up free →

No verified contacts on record for this company yet.

Sign up to unlock all 1 contacts at Metamol Theranostics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 1 verified contacts at Metamol Theranostics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Metamol Theranostics | Kipplo Discover